Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - Do not miss vaccination before starting therapy

Zeitschrift fur Gastroenterologie

Volumn 46, Issue 9, 2008, Pages 880-882

  Hadem, J ^a   Cornberg, M ^a   Hauptmann, C ^b   Suttmann U ^c   Manns, M P ^a   Wedemeyer, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Hospital Lehrte

^c Outpatient Clinic Lehrte

Author keywords

Bacterial meningitis; Hepatitis C; Interferon; Non response; Pneumococcus; Ribavirin; Splenectomy; Vaccination

Indexed keywords

CEFOTAXIME; CONSENSUS INTERFERON; IMMUNOMODULATING AGENT; LEVOFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; RECOMBINANT ALPHA2A INTERFERON; RIBAVIRIN;

ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DRUG MEGADOSE; DRUG TOLERABILITY; HEARING IMPAIRMENT; HEPATITIS C; HUMAN; IMMUNOMODULATION; INNER EAR DISEASE; MALE; SPLENECTOMY; STREPTOCOCCUS PNEUMONIAE; TREATMENT RESPONSE; VACCINATION;

ADULT; ANTIVIRAL AGENTS; BACTERIAL PROTEINS; CEFOTAXIME; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEARING LOSS, UNILATERAL; HEPATITIS C, CHRONIC; HUMANS; INFUSIONS, INTRAVENOUS; INTERFERON TYPE I, RECOMBINANT; MALE; MENINGITIS, PNEUMOCOCCAL; OPPORTUNISTIC INFECTIONS; PENICILLIN G; PNEUMOCOCCAL VACCINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RIBAVIRIN; RISK FACTORS; SPLENECTOMY;

EID: 54049098876     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027149     Document Type: Article

References (17)

1. Örtqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Sem Resp Crit Care Med 2005; 26: 563-574
2. Bisharat N, Omari H, Lavi I et al. Risk of infection and death among post-splenectomy patients. J Infect 2001; 43: 182-186
3. Durand ML, Calderwood SB, Weber DJ et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328: 21-28
4. Schuchat A, Robinson K, Wenger JD et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337: 970-976
5. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults - spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003; 126: 1015-1025
6. Scheld M, Koedel U, Nathan B et al. Pathophysiology of bacterial meningitis: mechanisms of neuronal injury. J Infect Dis 2002; 186 (Suppl 2): S225-233
7. Global burden of hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44: 20-29
8. Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 2006; 55: 1350-1359
9. Cooper CL, Al-Bedwawi L, Lee C et al. Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia. Clin Infect Diseases 2006; 42: 1674
10. Puoti M, Babudieri S, Rezza G et al. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antiviral Therapy 2004; 9: 627-630
11. Vander T, Medvedovsky M, Hallevy C et al. Listeria monocytogenes meningitis in a patient with chronic hepatitis C infection, treated by interferon alpha and ribavirin. Infection 2003; 46: 70-71
12. Cornberg M, Hadem J, Herrmann E et al. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study. J Hepatol 2006; 44: 291-301
13. Robert-Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut 2006. Epidemiologisches Bulletin 2006; 30: 235-254
14. Dear K, Holden J, Andrews R et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2003; 4: CD000422
15. Melegaro A, Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine, I: Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol 2004; 19: 353-563
16. Butler JC, Breiman RF, Campbell JF et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270: 1826-1831
17. Potthoff A, Sarhaddar J, Wiegand J et al. Spontaneous resolution of chronic hepatitis C virus infection after antiviral therapy and relapse. Hepatol Res 2005; 31: 18-23